Stifel Financial Corp Ascendis Pharma A/S Transaction History
Stifel Financial Corp
- $85.8 Billion
- Q1 2024
A detailed history of Stifel Financial Corp transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Stifel Financial Corp holds 13,160 shares of ASND stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,160
Previous 12,581
4.6%
Holding current value
$1.78 Million
Previous $1.58 Million
25.57%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding ASND
# of Institutions
212Shares Held
46.6MCall Options Held
310KPut Options Held
306K-
Artisan Partners Limited Partnership Milwaukee, WI5.67MShares$767 Million1.32% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.08MShares$551 Million3.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.97MShares$536 Million7.23% of portfolio
-
Janus Henderson Group PLC London, X03.77MShares$509 Million0.32% of portfolio
-
Wellington Management Group LLP Boston, MA2.75MShares$371 Million0.08% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.55B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...